MedPath

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

TEHRAN UNIVERSITY OF MEDICAL SCIENCES logo
🇮🇷Iran
Ownership
Private
Established
1934-01-01
Employees
1K
Market Cap
-
Website
http://www.tums.ac.ir

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Phase 3
Completed
Conditions
Uncontrolled Type 2 Diabetes Mellitus
Interventions
First Posted Date
2017-04-24
Last Posted Date
2017-04-24
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
250
Registration Number
NCT03125694
Locations
🇮🇷

Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

Phase 4
Completed
Conditions
Hepatitis C, Chronic
Chronic Renal Failure
Interventions
First Posted Date
2017-02-24
Last Posted Date
2019-09-30
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
95
Registration Number
NCT03063879
Locations
🇮🇷

Shariati Hospital, Tehran, Iran, Islamic Republic of

Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.

Phase 2
Conditions
Refractory Epilepsy
Interventions
Other: ketogenic diet
First Posted Date
2017-01-25
Last Posted Date
2017-01-25
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
30
Registration Number
NCT03031028
Locations
🇮🇷

Tehran university of medical science, school of nutritional science and dietetics, Tehran, Iran, Islamic Republic of

Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy

Phase 2
Completed
Conditions
Epilepsy Intractable
Interventions
Other: Classical ketogenic diet
Other: Modified Atkins diet
First Posted Date
2017-01-09
Last Posted Date
2017-09-07
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
50
Registration Number
NCT03014752
Locations
🇮🇷

Childrens' Medical Center, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes .

Phase 2
Conditions
Type2 Diabetes
Interventions
Dietary Supplement: vitamin D
Dietary Supplement: vitamin D placebo
First Posted Date
2017-01-02
Last Posted Date
2021-07-22
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
42
Registration Number
NCT03008057

Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

Phase 4
Completed
Conditions
Diabetic Nephropathies
Interventions
First Posted Date
2016-12-30
Last Posted Date
2016-12-30
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
59
Registration Number
NCT03006952
Locations
🇮🇷

Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Endo-nasal Endoscopic DCR and External-DCR in Primary Nasolacrimal Duct Obstruction

Not Applicable
Conditions
Primary Acquired Nasolacrimal
Interventions
Procedure: Endoscopic DCR
Procedure: External DCR
First Posted Date
2016-12-15
Last Posted Date
2020-02-05
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
120
Registration Number
NCT02993770
Locations
🇮🇷

Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

a Population Based Study on Metabolic Syndrome Complications, and Mortality

Conditions
Metabolic Syndrome X
Interventions
Other: No intervention will be done. Participants are on standard care and the treatments will be recorded because of observational nature of this study.
First Posted Date
2016-11-08
Last Posted Date
2016-11-08
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
10000
Registration Number
NCT02958579
Locations
🇮🇷

Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Effect of Phenytoin on the Ganglion Cell Layer in Patients With Optic Neuritis

Phase 2
Completed
Conditions
Optic Neuritis
Interventions
Drug: placebo
First Posted Date
2016-10-20
Last Posted Date
2019-08-12
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
71
Registration Number
NCT02939937
Locations
🇮🇷

Eye Research Center Farabi Hosoital, Tehran, Iran, Islamic Republic of

Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation

Phase 4
Completed
Conditions
Ketamine Induced Agitation
Interventions
First Posted Date
2016-09-21
Last Posted Date
2017-11-07
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
185
Registration Number
NCT02909465
Locations
🇮🇷

Sina Hospital, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath